AbbVie Inc. — Director's Dealing 2013

Feb 19, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-02-14

Reporting Person: LEONARD JOHN M. (SVP, Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-14	Common stock, $0.01 par value	A	30360	$0.00	Acquired	152658	Direct
2013-02-19	Common stock, $0.01 par value	F	7982	$37.58	Disposed	144676	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-14	Option (right to buy)	$35.88	A	62020	Acquired	2023-02-13	Common stock (62020)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	6473	Indirect

Footnotes

F1: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the AbbVie Savings Program as of February 14, 2013.

F3: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 20,674 on 02/14/2014, 20,673 on 02/14/2015, and 20,673 on 02/14/2016.